Celldex Therapeutics Inc is a biopharmaceutical company. The Company is engaged in the development and commercialization of immunotherapy technologies for the treatment of cancer and other difficult-to-treat diseases.
| Website: | www.celldex.com |
| Email: | ir@celldextherapeutics.com |
| Main Phone: | +1 908 200-7500 |
| Address: | 53 Frontage Road |
| Address 2: | Suite 200 |
| State: | NJ |
| City / Town: | Hampton |
| Country: | USA |
| Postal Code: | 08827 |
| Exchange: | NGS |
| Employees: | 197 |
| NAICS: | In-Vitro Diagnos |
| Last Price 2.33 | Change $ -0.03 | Change % -1.27 | Tick N/A |
| Bid 2.08 | Bid Size 100.00 | Ask 2.79 | Ask Size 200.00 |
| Open 2.34 | High 2.35 | Low 2.30 | Prev Close 2.36 |
| Last Trade | Volume 726,077 | 52 Wk Hi 5.02 | 52 Wk Low 2.20 |
| Market Cap 299 mi | Ex-Div Date N/A | Div Rate N/A | Yield N/A |
| Shares 128,341,785.00 | EPS (TTM) -1.10 | PE Ratio N/A | Exchange NGS |
|
|
|
|
| Last 3 Mo | Last 12 Mo | |
|---|---|---|
| Number of Insider Trades | 8 | 13 |
| Number of Buys | 8 | 12 |
| Number of Sells | 0 | 1 |
| Net Activity | 82847 | 112847 |
| Last 10 Buys | Shares |
|---|---|
| Larry Ellberger | 1,000 |
| Larry Ellberger | 1,000 |
| Larry Ellberger | 1,000 |
| Larry Ellberger | 1,000 |
| Larry Ellberger | 1,000 |
| Larry Ellberger | 1,000 |
| Anthony S. Marucci | 1,000 |
| Tibor Keler | 1,000 |
| Avery W. Catlin | 1,000 |
| Anthony S. Marucci | 1,000 |
| Last 10 Sell | Shares |
|---|---|
| Avery W. Catlin | 1,000 |
| Avery W. Catlin | 1,000 |
| Avery W. Catlin | 1,000 |
| Larry Ellberger | 1,000 |
| Harry H. Penner | 1,000 |
| Karen L. Shoos | 1,000 |
| Current | 1 Week Ago | 2 Weeks Ago | 3 Weeks Ago | |
|---|---|---|---|---|
| High Target Price Estimate | 24 | 24 | 24 | 24 |
| Low Target Price Estimate | 3 | 3 | 3 | 3 |
| Mean Target Price Estimate | 8.75 | 8.63 | 8.63 | 8.75 |
| Standard Deviation | 6.8 | 6.89 | 6.89 | 6.8 |
| Date of Most Recent Estimate | 08/11/16 | 06/06/16 | 06/06/16 | 08/11/16 |
| Form Type | Form Description | Pages | Date |
|---|---|---|---|
| 3 | Initial statement of beneficial ownership of securities | 1 | 2016-08-12 |
| 8-K | Report of unscheduled material events or corporate changes. | 19 | 2016-08-11 |
| 10-Q | Quarterly report with a continuing view of a company's financial position | 32 | 2016-08-08 |
| 8-K | Report of unscheduled material events or corporate changes. | 4 | 2016-08-08 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2016-06-09 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2016-06-09 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2016-06-09 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2016-06-09 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2016-06-09 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2016-06-09 |
| Current | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
|---|---|---|---|---|
| Strong Buy | 5 | 5 | 5 | 5 |
| Moderate Buy | 0 | 0 | 0 | 0 |
| Hold | 4 | 4 | 5 | 5 |
| Moderate Sell | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 |
| Mean Rec. | 1.89 | 1.89 | 2 | 2 |
© 2017 Equities
* All dates and time are being displayed in Eastern Standard Time (EST).
